{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:40:53Z","timestamp":1784133653006,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jjcc.2017.08.008","type":"journal-article","created":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T05:45:40Z","timestamp":1506750340000},"page":"277-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Chronic kidney disease, inflammation, and cardiovascular disease risk in rheumatoid arthritis"],"prefix":"10.1016","volume":"71","author":[{"given":"Masako","family":"Kochi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Kohagura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Shiohira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunitoshi","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ohya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2017.08.008_bib0230","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/rheumatology\/kep252","article-title":"Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies","volume":"48","author":"Meune","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0235","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0240","first-page":"673","article-title":"Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature","volume":"26","author":"L\u00e9vy","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0245","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/ard.2009.122226","article-title":"Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity","volume":"69","author":"Solomon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0250","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jjcc.2014.12.003","article-title":"Catheter ablation of atrial fibrillation in patients with rheumatoid arthritis","volume":"66","author":"Wen","year":"2015","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0255","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avi\u00f1a-Zubieta","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0260","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.24836","article-title":"Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease?. A prospective study","volume":"61","author":"Peters","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0265","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0270","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/sj.ki.5000284","article-title":"The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population","volume":"69","author":"Irie","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0275","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1523-1755.2005.00397.x","article-title":"Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study","volume":"68","author":"Ninomiya","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0280","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.164.6.659","article-title":"Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization","volume":"164","author":"Keith","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0285","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.2006101159","article-title":"Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study","volume":"18","author":"Kottgen","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0290","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/kem370","article-title":"Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study","volume":"47","author":"Karie","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0295","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s10067-007-0625-y","article-title":"Prognosis of clinical renal disease and incidence of new renal findings in patients with rheumatoid arthritis: follow-up of a population-based study","volume":"26","author":"Karstila","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0300","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/annrheumdis-2011-200051","article-title":"Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARR\u00c9 Study","volume":"71","author":"van Sijl","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0305","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.ajkd.2013.08.010","article-title":"Development of reduced kidney function in rheumatoid arthritis","volume":"63","author":"Hickson","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0310","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0315","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0320","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1523-1755.2005.00551.x","article-title":"Cardiovascular risk factors in chronic kidney disease","volume":"68","author":"Menon","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0325","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1523-1755.2005.00455.x","article-title":"C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease","volume":"68","author":"Menon","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0330","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1523-1755.2004.00465.x","article-title":"Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease","volume":"65","author":"Oberg","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0335","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.22482","article-title":"HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis","volume":"57","author":"Gonzalez-Gay","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0340","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/art.21204","article-title":"Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort","volume":"52","author":"Goodson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0345","first-page":"2562","article-title":"Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset","volume":"26","author":"W\u00e5llberg-Jonsson","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0350","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0355","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10157-009-0163-9","article-title":"CKD clinical practice guidebook. The essence of treatment for CKD patients","volume":"13","author":"Ando","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0360","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5551\/jat.E578","article-title":"Risk factors of atherosclerotic diseases. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese","volume":"14","author":"Teramoto","year":"2007","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0365","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0370","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.CIR.88.1.107","article-title":"Survival after the onset of congestive heart failure in Framingham Heart Study subjects","volume":"88","author":"Ho","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0375","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1756-185X.2011.01594.x","article-title":"A comparative study of renal dysfunction in patients with inflammatory arthropathies: strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis","volume":"14","author":"Haroon","year":"2011","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-11-1","article-title":"The relation of C-reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study","volume":"11","author":"Fox","year":"2010","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0385","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.0000042700.48769.59","article-title":"Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency","volume":"107","author":"Shlipak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0390","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1046\/j.1523-1755.2003.00762.x","article-title":"C-reactive protein is associated with renal function abnormalities in a non-diabetic population","volume":"63","author":"Stuveling","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0395","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.4049\/jimmunol.161.5.2524","article-title":"Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure","volume":"161","author":"Witko-Sarsat","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0400","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.4049\/jimmunol.150.5.2007","article-title":"Influence of nephrectomy on tumor necrosis factor clearance in a murine model","volume":"150","author":"Bemelmans","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0405","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.CIR.0000052617.91920.FD","article-title":"C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis","volume":"107","author":"Devaraj","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0410","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","article-title":"Direct proinflammatory effect of C-reactive protein on human endothelial cells","volume":"102","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0415","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/ki.2008.75","article-title":"Inflammation and cardiovascular events in individuals with and without chronic kidney disease","volume":"73","author":"Weiner","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0420","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","article-title":"The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review","volume":"49","author":"Westlake","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0425","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0430","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0435","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar2045","article-title":"Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study","volume":"8","author":"van Halm","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0440","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0445","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study","volume":"10","author":"Naranjo","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jjcc.2017.08.008_bib0450","doi-asserted-by":"crossref","first-page":"e6242","DOI":"10.1371\/journal.pone.0006242","article-title":"Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis","volume":"4","author":"Graf","year":"2009","journal-title":"PLoS One"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450871730240X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450871730240X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:58:56Z","timestamp":1760273936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S091450871730240X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S091450871730240X"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2017.08.008","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic kidney disease, inflammation, and cardiovascular disease risk in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2017.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}